Logo image of ACR

ACRES COMMERCIAL REALTY CORP (ACR) Stock Fundamental Analysis

NYSE:ACR - US00489Q1022 - REIT

21.02 USD
+0.22 (+1.06%)
Last: 8/26/2025, 8:13:50 PM
Fundamental Rating

2

Taking everything into account, ACR scores 2 out of 10 in our fundamental rating. ACR was compared to 67 industry peers in the Mortgage Real Estate Investment Trusts (REITs)" industry. While ACR is still in line with the averages on profitability rating, there are concerns on its financial health. ACR is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

ACR had negative earnings in the past year.
ACR had a positive operating cash flow in the past year.
In multiple years ACR reported negative net income over the last 5 years.
ACR had a positive operating cash flow in each of the past 5 years.
ACR Yearly Net Income VS EBIT VS OCF VS FCFACR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M -200M

1.2 Ratios

With a Return On Assets value of 0.02%, ACR is not doing good in the industry: 62.69% of the companies in the same industry are doing better.
The Return On Equity of ACR (0.08%) is worse than 62.69% of its industry peers.
With a decent Return On Invested Capital value of 0.57%, ACR is doing good in the industry, outperforming 68.66% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for ACR is in line with the industry average of 1.32%.
The last Return On Invested Capital (0.57%) for ACR is above the 3 year average (0.53%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 0.02%
ROE 0.08%
ROIC 0.57%
ROA(3y)0.08%
ROA(5y)-2.31%
ROE(3y)0.25%
ROE(5y)-11.49%
ROIC(3y)0.53%
ROIC(5y)N/A
ACR Yearly ROA, ROE, ROICACR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20 -40 -60

1.3 Margins

ACR has a Profit Margin of 0.18%. This is in the lower half of the industry: ACR underperforms 62.69% of its industry peers.
In the last couple of years the Profit Margin of ACR has declined.
ACR has a Operating Margin (6.47%) which is comparable to the rest of the industry.
In the last couple of years the Operating Margin of ACR has declined.
ACR has a Gross Margin of 42.19%. This is amongst the best in the industry. ACR outperforms 83.58% of its industry peers.
ACR's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 6.47%
PM (TTM) 0.18%
GM 42.19%
OM growth 3Y-46.25%
OM growth 5Y-26.58%
PM growth 3Y-34.18%
PM growth 5Y-23.68%
GM growth 3Y-1.09%
GM growth 5Y1.39%
ACR Yearly Profit, Operating, Gross MarginsACR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 200

2

2. Health

2.1 Basic Checks

ACR has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
ACR has less shares outstanding than it did 1 year ago.
ACR has less shares outstanding than it did 5 years ago.
Compared to 1 year ago, ACR has an improved debt to assets ratio.
ACR Yearly Shares OutstandingACR Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M
ACR Yearly Total Debt VS Total AssetsACR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

2.2 Solvency

Based on the Altman-Z score of -0.46, we must say that ACR is in the distress zone and has some risk of bankruptcy.
ACR has a worse Altman-Z score (-0.46) than 62.69% of its industry peers.
ACR has a Debt/Equity ratio of 2.78. This is a high value indicating a heavy dependency on external financing.
With a decent Debt to Equity ratio value of 2.78, ACR is doing good in the industry, outperforming 73.13% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 2.78
Debt/FCF N/A
Altman-Z -0.46
ROIC/WACC0.08
WACC6.93%
ACR Yearly LT Debt VS Equity VS FCFACR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B

2.3 Liquidity

A Current Ratio of 0.31 indicates that ACR may have some problems paying its short term obligations.
ACR has a Current ratio (0.31) which is comparable to the rest of the industry.
A Quick Ratio of 0.31 indicates that ACR may have some problems paying its short term obligations.
With a Quick ratio value of 0.31, ACR perfoms like the industry average, outperforming 59.70% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.31
Quick Ratio 0.31
ACR Yearly Current Assets VS Current LiabilitesACR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

2

3. Growth

3.1 Past

ACR shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -105.13%.
The earnings per share for ACR have been decreasing by -15.41% on average. This is quite bad
The Revenue for ACR has decreased by -15.89% in the past year. This is quite bad
The Revenue has been growing slightly by 6.60% on average over the past years.
EPS 1Y (TTM)-105.13%
EPS 3Y-14.58%
EPS 5Y-15.41%
EPS Q2Q%-92.16%
Revenue 1Y (TTM)-15.89%
Revenue growth 3Y21.05%
Revenue growth 5Y6.6%
Sales Q2Q%4.48%

3.2 Future

The Earnings Per Share is expected to grow by 3.35% on average over the next years.
Based on estimates for the next years, ACR will show a decrease in Revenue. The Revenue will decrease by -3.17% on average per year.
EPS Next Y-36.42%
EPS Next 2Y3.35%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year2.76%
Revenue Next 2Y-3.17%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
ACR Yearly Revenue VS EstimatesACR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 100M 200M
ACR Yearly EPS VS EstimatesACR Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 2 -2 4 -4

2

4. Valuation

4.1 Price/Earnings Ratio

ACR reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
The Price/Forward Earnings ratio is 14.16, which indicates a correct valuation of ACR.
Compared to the rest of the industry, the Price/Forward Earnings ratio of ACR is on the same level as its industry peers.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.67, ACR is valued a bit cheaper.
Industry RankSector Rank
PE N/A
Fwd PE 14.16
ACR Price Earnings VS Forward Price EarningsACR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 -50 -100 -150 -200

4.2 Price Multiples

ACR's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. ACR is cheaper than 85.07% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 56.65
ACR Per share dataACR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30 40 50

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y3.35%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

ACR does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

ACRES COMMERCIAL REALTY CORP

NYSE:ACR (8/26/2025, 8:13:50 PM)

21.02

+0.22 (+1.06%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryMortgage Real Estate Investment Trusts (REITs)"
Earnings (Last)07-30 2025-07-30/amc
Earnings (Next)10-28 2025-10-28/amc
Inst Owners41.79%
Inst Owner Change18.67%
Ins Owners3.47%
Ins Owner Change-0.12%
Market Cap156.18M
Analysts76.67
Price Target22.44 (6.76%)
Short Float %4.33%
Short Ratio5.49
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend2.58
Dividend Growth(5Y)-6.04%
DP6513.31%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-169.78%
Min EPS beat(2)-262.19%
Max EPS beat(2)-77.37%
EPS beat(4)1
Avg EPS beat(4)-74.95%
Min EPS beat(4)-262.19%
Max EPS beat(4)79.34%
EPS beat(8)4
Avg EPS beat(8)-35.48%
EPS beat(12)8
Avg EPS beat(12)-15.84%
EPS beat(16)10
Avg EPS beat(16)-25.89%
Revenue beat(2)1
Avg Revenue beat(2)-8.17%
Min Revenue beat(2)-22.92%
Max Revenue beat(2)6.58%
Revenue beat(4)2
Avg Revenue beat(4)-3.69%
Min Revenue beat(4)-22.92%
Max Revenue beat(4)6.58%
Revenue beat(8)4
Avg Revenue beat(8)0.67%
Revenue beat(12)8
Avg Revenue beat(12)30.82%
Revenue beat(16)12
Avg Revenue beat(16)55.98%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)62.22%
EPS NQ rev (3m)-30.7%
EPS NY rev (1m)68.27%
EPS NY rev (3m)68.27%
Revenue NQ rev (1m)10.17%
Revenue NQ rev (3m)6.52%
Revenue NY rev (1m)6.94%
Revenue NY rev (3m)6.94%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 14.16
P/S 0.86
P/FCF N/A
P/OCF 9.42
P/B 0.37
P/tB 0.37
EV/EBITDA 56.65
EPS(TTM)-0.1
EYN/A
EPS(NY)1.48
Fwd EY7.06%
FCF(TTM)-0.61
FCFYN/A
OCF(TTM)2.23
OCFY10.62%
SpS24.3
BVpS57.24
TBVpS56.34
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.02%
ROE 0.08%
ROCE 0.72%
ROIC 0.57%
ROICexc 0.58%
ROICexgc 0.59%
OM 6.47%
PM (TTM) 0.18%
GM 42.19%
FCFM N/A
ROA(3y)0.08%
ROA(5y)-2.31%
ROE(3y)0.25%
ROE(5y)-11.49%
ROIC(3y)0.53%
ROIC(5y)N/A
ROICexc(3y)0.55%
ROICexc(5y)N/A
ROICexgc(3y)0.55%
ROICexgc(5y)N/A
ROCE(3y)0.67%
ROCE(5y)N/A
ROICexcg growth 3Y-27.63%
ROICexcg growth 5Y-15.6%
ROICexc growth 3Y-27.72%
ROICexc growth 5Y-15.71%
OM growth 3Y-46.25%
OM growth 5Y-26.58%
PM growth 3Y-34.18%
PM growth 5Y-23.68%
GM growth 3Y-1.09%
GM growth 5Y1.39%
F-Score6
Asset Turnover0.1
Health
Industry RankSector Rank
Debt/Equity 2.78
Debt/FCF N/A
Debt/EBITDA 47.07
Cap/Depr 157%
Cap/Sales 11.68%
Interest Coverage 0.12
Cash Conversion 66.05%
Profit Quality N/A
Current Ratio 0.31
Quick Ratio 0.31
Altman-Z -0.46
F-Score6
WACC6.93%
ROIC/WACC0.08
Cap/Depr(3y)766.24%
Cap/Depr(5y)459.83%
Cap/Sales(3y)30.67%
Cap/Sales(5y)18.41%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-105.13%
EPS 3Y-14.58%
EPS 5Y-15.41%
EPS Q2Q%-92.16%
EPS Next Y-36.42%
EPS Next 2Y3.35%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-15.89%
Revenue growth 3Y21.05%
Revenue growth 5Y6.6%
Sales Q2Q%4.48%
Revenue Next Year2.76%
Revenue Next 2Y-3.17%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-34.43%
EBIT growth 3Y-34.93%
EBIT growth 5Y-21.74%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-125.11%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-61.82%
OCF growth 3Y-21.84%
OCF growth 5Y-14.85%